期刊文献+

补肺益肾膏对慢性阻塞性肺疾病稳定期患者生活质量影响的评价研究 被引量:6

Clinical Study on the Effects of Bufei Yishen Treatment on Quality of Life of Patients with Chronic Obstructive Pulmonary Disease in Stable Period
下载PDF
导出
摘要 目的观察补肺益肾膏对慢性阻塞性肺疾病稳定期患者生活质量的影响。方法将64例患者随机分为2组,对照组(32例)予异丙托溴铵气雾剂吸入及沐舒坦口服治疗,治疗组(32例)在对照组用药基础上加用补肺益肾膏治疗,3个月为1个疗程。主要观察治疗前后中医证候和主症积分、生活质量评分及肺功能测定结果的变化。结果治疗组治疗后中医证候、主症积分及生活质量评分明显优于对照组(P < 0.05),肺功能测定结果无明显变化(P > 0.05)结论补肺益肾法对慢性阻塞性肺疾病稳定期患者生活质量确有疗效。 Objective To observe the clinical effects of Bufei Yishen treatment on quality of life of patients with chronic obstructive pulmonary disease in stable period. Methods Sixty-four patients were randomly divided into two groups, the control group (32 cases) received Atrovent metered dose inhaling and Mucosolvan po. The treatment group {32 cases) received the fluid extract of Bufei Yishen besides the routine treatment. Both groups were treated for three months. The changes of scores of TCM syndrome and cardinal symptom, quality of life (QOL), lung function were observed before and after the treatment. Results The scores of TCM syndrome and cardinal symptom, quality of life of the treatment group were significantly higher than the control group (P〈0.05), though the change of lung function was not obvious (P 〉0.05). Condusion Bufei Yishen treatment has significantly effect on quality of life of patients with chronic obstructive pulmonary disease in stable period.
出处 《中国中医药信息杂志》 CAS CSCD 2009年第12期13-15,共3页 Chinese Journal of Information on Traditional Chinese Medicine
基金 首都医学发展科研基金重点支持课题(2005-sF-Ⅱ-024) 中国中医科学院广安门医院优势病种课题(820107)
关键词 补肺益肾膏 慢性阻塞性肺疾病 稳定期 生活质量 Bufei Yishen fluid chronic obstructive pulmonary disease stable period quality of life
  • 相关文献

参考文献8

二级参考文献17

  • 1柳涛,蔡柏蔷.慢性阻塞性肺疾病患者生活质量评估方法及其意义[J].中国呼吸与危重监护杂志,2003,2(4):196-197. 被引量:54
  • 2崔德健.探讨慢性阻塞性肺疾病诊断的进展[J].中华结核和呼吸杂志,2005,28(2):80-82. 被引量:16
  • 3方药中 邓铁涛.实用中医内科学[M].上海:上海科学技术出版社,1995.276.
  • 4Pauwels RA,Buist AS,Calverley PM,et al. Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med,2001,163:1256-1276.
  • 5Gross NJ. Outcome measures for COPD treatments:a critical evaluation. COPD,2004,1:41-57.
  • 6Celli BR,MacNee W,ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper. Eur Respir J,2004,23:932-946.
  • 7Marin JM,Carrizo SJ,Gascon M,et al. Inspiratory capacity,dynamic hyperinflation,breathlessness,and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med,2001,163:1395-1399.
  • 8Redelmeier DA,Bayoumi AM,Goldstein RS,et al. Interpreting small differences in functional status:the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med,1997,155:1278-1282.
  • 9Curtis JR,Patrick DL. The assessment of health status among patients with COPD. Eur Respir J Suppl,2003,41:36s-45s.
  • 10Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest,2000,117(5 Suppl 2):398S-401S.

共引文献5287

同被引文献73

引证文献6

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部